News
26 Feb 2026
Zydus to Launch Semaglutide Injection in India on Patent Expiry Day, Backed by First-of-Its-Kind Reusable Pen Device
Zydus Lifesciences is preparing to enter India's rapidly growing GLP-1 therapy market the moment the Semaglutide patent expires, with a…
